[go: up one dir, main page]

NL7006453A - - Google Patents

Info

Publication number
NL7006453A
NL7006453A NL7006453A NL7006453A NL7006453A NL 7006453 A NL7006453 A NL 7006453A NL 7006453 A NL7006453 A NL 7006453A NL 7006453 A NL7006453 A NL 7006453A NL 7006453 A NL7006453 A NL 7006453A
Authority
NL
Netherlands
Application number
NL7006453A
Other versions
NL142589B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7006453A publication Critical patent/NL7006453A/xx
Publication of NL142589B publication Critical patent/NL142589B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NL707006453A 1969-05-07 1970-05-01 Werkwijze voor het op in de farmacie gebruikelijke wijze bereiden van stabiele waterige oplossingen van een zout van een 21-fosfaat van een 21-hydroxysteroide, geschikt voor parenterale toediening. NL142589B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1644669 1969-05-07

Publications (2)

Publication Number Publication Date
NL7006453A true NL7006453A (fr) 1970-11-10
NL142589B NL142589B (nl) 1974-07-15

Family

ID=11148881

Family Applications (1)

Application Number Title Priority Date Filing Date
NL707006453A NL142589B (nl) 1969-05-07 1970-05-01 Werkwijze voor het op in de farmacie gebruikelijke wijze bereiden van stabiele waterige oplossingen van een zout van een 21-fosfaat van een 21-hydroxysteroide, geschikt voor parenterale toediening.

Country Status (8)

Country Link
US (1) US3696195A (fr)
BE (1) BE750065A (fr)
DE (1) DE2021446A1 (fr)
ES (1) ES379001A1 (fr)
FR (1) FR2051504B1 (fr)
GB (1) GB1270614A (fr)
IL (1) IL34366A (fr)
NL (1) NL142589B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164570A (en) * 1973-09-24 1979-08-14 David Clough Stabilized aqueous catecholamine solutions
US5173488A (en) * 1989-08-21 1992-12-22 American Cyanamid Company Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
DE102009032298A1 (de) 2009-07-09 2011-01-13 Bergander, Klaus, Dr. Thiol-funktionalisierte copolymere Polyester durch enzymkatalysierte Veresterungsreaktionen
EP3189855B1 (fr) * 2016-01-11 2018-03-21 Lamda Laboratories S.A. Solutions pharmaceutiques orales de phosphate de sodium contenant de l'hydrocortisone
CN116367835A (zh) * 2020-09-21 2023-06-30 安塔雷斯药品公司 氢化可的松磷酸钠和单硫代甘油的水性药物调配物
FR3128874A1 (fr) * 2021-11-09 2023-05-12 Crossject Solution pharmaceutique d’hydrocortisone pour dispositif d’injection
WO2023183807A1 (fr) * 2022-03-21 2023-09-28 Antares Pharma, Inc. Formulation pharmaceutique aqueuse de phosphate de sodium d'hydrocortisone et de monothioglycérol
EP4496575A1 (fr) * 2022-03-21 2025-01-29 Antares Pharma, Inc. Formulation pharmaceutique aqueuse de phosphate de sodium d'hydrocortisone et de monothioglycérol
US11904046B1 (en) 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498200A (en) * 1948-08-27 1950-02-21 Lilly Co Eli Stabilized thiamin
US2719812A (en) * 1953-08-07 1955-10-04 Merck & Co Inc Stabilized aqueous solutions of streptomycin
US3146164A (en) * 1960-08-09 1964-08-25 Merck & Co Inc Solutions of steroid phosphate and basic antibiotics stabilized with creatinine

Also Published As

Publication number Publication date
IL34366A (en) 1973-06-29
FR2051504B1 (fr) 1973-08-10
US3696195A (en) 1972-10-03
DE2021446A1 (de) 1970-11-19
GB1270614A (en) 1972-04-12
NL142589B (nl) 1974-07-15
ES379001A1 (es) 1972-08-01
IL34366A0 (en) 1970-06-17
BE750065A (fr) 1970-10-16
FR2051504A1 (fr) 1971-04-09

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
AU429630B2 (fr)
CS151016B2 (fr)
FR2051504B1 (fr)
CS148144B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442357B2 (fr)
AU442322B2 (fr)
AU442285B2 (fr)
AU428129B2 (fr)
AU470661B1 (fr)
AU438128B2 (fr)
CS148412B1 (fr)
CS153151B1 (fr)
CS149286B1 (fr)
AU5133369A (fr)
AU4540468A (fr)
AU4923469A (fr)
AU4949169A (fr)
AU5077469A (fr)
AU5079269A (fr)
CS151580B2 (fr)
BE740386A (fr)
BE731374A (fr)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: LEPETIT